University of Wisconsin–Madison

Pharmacy Innovations Conference on Antithrombotic Therapy (PICAT)

Developed & Conducted by the Division of Pharmacy Professional Development, School of Pharmacy, University of Wisconsin-Madison.

This program is designed to provide pharmacists with current information on antithrombotic therapies and to increase their knowledge and skills required to promote the appropriate management of patients. Special attention this year to the discussion of antithrombotics therapy affected by COVID-19.

This conference is made possible in part through educational grants from: Bristol Myers Sqibb, CSL Behring and Portola Pharmaceuticals

In order to fit the traditional number of lectures into a reasonable live virtual format, half of the lectures will be available two weeks prior to the live conference. All speakers will be available for Q and A at the live session.  All talks will be available to registrants after the meeting for further review. An after-conference networking session will take place on Dec 5, 2020.

Registration Information

Register

Refund Policy

Course date:Dec 5, 2020
Location:
Course fee:

$100 early registration
$125 after November 23, 2020

Half of the lectures will be pre-recorded and available Nov 21.
The remainder of the lectures will be via live webinar on Dec 5 at the following times:

7:00 am – 1:30 pm PST

9:00 am – 2:30 pm CST

10:00 am – 3:30 pm EST

The program fee includes  instruction and CE credit.

Refund policy: A refund minus a $35 administrative fee will be provided up to November 23, 2020. After Novemeber 23, no refunds will be provided.

Course Objectives

This program is designed to provide pharmacists with current information on antithrombotic therapy and to increase their knowledge and skills required to promote the appropriate management of patients. Upon completion of the program, the learner should be able to:

  • Describe, analyze, and critique recent antithrombotic clinical trial results and project their impact on patient care.
  • Discuss agents available and consideration for using in the management pf patients on anticoagulation therapy who are bleeding. This will include decisions on restarting anticoagulation once bleeding issues begin to subside.
  • Discuss, how to use laboratory data to manage transitions in anticoagulant therapy, how laboratory data including standard coagulation assays and DOAC specific tests can guide patient management decisions and the fundamentals of laboratory testing involved in thrombophilia evaluation including antiphospholipid antibody syndrome.
  • Discuss how to approach a new paradigm in use of anticoagulants to manage a specific situation. This will include how to revise the standard approach to therapy that adapts to new challenges thrombosis management are present.
  • Identify current issues of controversy in the prevention of thromboembolism in patients with valvular disease
  • Describe the potential risks and benefits with the use of anticoagulation for treatment and prevention of thromboembolic disease in the extreme elderly patient population. The participant should be able to describe key factors, such as comorbidities and concomitant medications for consideration in development an individualized plan of care and optimal anticoagulant agent selection.
  • Describe the risk of COVID-19 related thromboembolism (TE), appropriate treatment and preventions strategies, including post discharge venous thromboembolism (VTE) prophylaxis.
  • Discuss the opportunities available to generate revenue for the anticoagulation clinic including how and when utilize billing codes for home INR management programs and at transitions of care.
  • Describe changes in anticoagulant drug therapy utilization in the United States, discuss the opportunities to improve the quality and safety of direct-acting oral anticoagulants (DOACs) and the role of anticoagulation clinics in anticoagulation management beyond warfarin.
  • Identify and apply electronic health record templates and applications to manage anticoagulation.

Course Outline

 

Recorded Presentations Available Prior to the Meeting

 

2020 Clinical Year in Review

Speaker: Scott Kaatz, DO, MSc, FACP, SFHM, Clinical Professor of Medicine - Wayne State University, Senior Staff Hospitalist, Medical Director for Professional Development and Research, Division of Hospital Medicine, Henry Ford Hospital

 

Anticoagulation Management Via Active Clinical Decision Support as a Component of Anticoagulation Stewardship

Speaker:  Kelly M. Rudd, PharmD, FCCP, BCPS, CACP,  Director, Network Pharmacy Operations Bassett Healthcare Network

 

Challenges in Unique Patient Populations

 

Valvular Disease and Anticoagulation

Speaker: Doug Anderson, RPh, PharmD, Professor of Pharmacy Practice, Cedarville University

 

Extreme Elderly and Anticoagulation

Speaker: Candice L. Garwood, PharmD, FCCP, BCPS, BCACP, Professor (Clinical), Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University

 

Increasing Reimbursement

Speaker: Anne Rose, PharmD, Pharmacy Manager, UW Health, University of Wisconsin Hospital and Clinics

 

Reinventing the Anticoagulation Clinic

Speaker: Nathan P. Clark, PharmD, FCCP, BCPS Pharmacy Supervisor, Clinical Pharmacy Anticoagulation and Anemia Service Kaiser Permanente Colorado

 

Practice Considerations When Adapting Anticoagulation Management Into a New Paradigm

Speaker: Allison Burnett, PharmD, PhC, CACP, Antithrombosis Stewardship Pharmacist     University of New Mexico Hospital, President Elect, Anticoagulation Forum

 

Saturday, December 5, 2020
Virtual

(all times Central time zone)

9:00 am

Welcome to the Morning Session

Andrea L. Porter, PharmD, Conference Chair and Morning Moderator
Associate Professor (CHS), University of Wisconsin‐Madison School of Pharmacy, Clinical Pharmacy Specialist, William S. Middleton Memorial Veterans Hospital, Madison, WI

9:10 am

Using Lab Data to Optimize Anticoagulation: A discussion between Laboratory Specialist and Pharmacist

Pharmacy
Speaker: Michael P. Gulseth, PharmD, BCPS, FASHP, Program Director for Anticoagulation Services, Sanford USD Medical Center, Clinical Associate Professor, University of South Dakota Sanford School of Medicine, President, Michael P Gulseth Anticoagulation Consulting, Inc.     

Laboratory
Speaker: Bob Gosselin, Clinical Laboratory Scientist, University of California, Davis Health System, Subcommittee of the Pharmacy and Therapeutics Committee on Thrombosis and Hemostasis

10:20 am

Discussion

10:30 am

Break

10:40 am

Panel discussion from recorded presentations

  • Valvular Disease ~ Doug Anderson
  • Elderly ~ Candice Garwood
  • Year in review ~ Scott Kaatz

11:00 am

Management of the Bleeding Patient

Broad overview
Speaker: William E. Dager, PharmD, BCPS-AQ Cardiology, MCCM, FCSHP, FCCP, FCCM, FASHP, Pharmacist Specialist, University of California, Davis Health System, Clinical Professor of Pharmacy, UC San Francisco School of Pharmacy, Clinical Professor of Medicine, UC Davis School of Medicine

Restarting Anticoagulation
Speaker:  Arthur Allen, PharmD, CACP, Clinical Pharmacy Specialist at U.S. Department of Veterans Affairs

11:50 am

Discussion

12:00 pm

Break

12:10 pm

Panel discussion from recorded presentations

  • Practice Considerations ~ Allison Burnett
  • Clinical decision support ~ Kelley Rudd
  • Reimbursement ~ Anne Rose
  • Reinventing the AC clinic ~ Nathan Clark

12:30 pm

COVID-19 Related Thromboembolic Disease; Lessons Learned from the Front Lines

Speaker: Thaddaus Hellwig, PharmDBCPS, FASHP, Professor, Department of Pharmacy Practice, South Dakota State University College of Pharmacy and Allied Health Professions, Clinical Pharmacist, Sanford USD Medical Center, Coordinator of the SD Drug Education and Evaluation Program

1:20 pm

Open Discussion/Closing comments

1:35 pm

Networking: Breakout Chat rooms with the experts: These networking sessions are intended to promote discussion of the topics among registrants, lead and moderated by our speakers.

2:30 pm

Conference conclusion

Instructors

Arthur Allen, PharmD, CACP, Clinical Pharmacy Specialist at U.S. Department of Veterans Affairs, Salt Lake City, UT

Doug Anderson, RPh, PharmD, Professor of Pharmacy Practice, Cedarville University, Cedarville, OH

Allison Burnett, PharmD, PhC, CACP, Antithrombosis Stewardship Pharmacist     University of New Mexico Hospital, President Elect, Anticoagulation Forum, Newton, MA

Nathan P. Clark, PharmD, FCCP, BCPS Pharmacy Supervisor, Clinical Pharmacy Anticoagulation and Anemia Service Kaiser Permanente Colorado, Aurora, Colorado

William E. Dager, PharmD, BCPS-AQ Cardiology, MCCM, FCSHP, FCCP, FCCM, FASHP, Pharmacist Specialist, University of California, Davis Health System, Clinical Professor of Pharmacy, UC San Francisco School of Pharmacy, Clinical Professor of Medicine, UC Davis School of Medicine, Sacramento, CA

Candice L. Garwood, PharmD, FCCP, BCPS, BCACP, Professor (Clinical), Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 

Bob Gosselin, Clinical Laboratory Scientist, University of California, Davis Health System, Subcommittee of the Pharmacy and Therapeutics Committee on Thrombosis and Hemostasis, Sacramento, CA

Michael P. Gulseth, PharmD, BCPS, FASHP, Program Director for Anticoagulation Services, Sanford USD Medical Center, Clinical Associate Professor, University of South Dakota Sanford School of Medicine, President, Michael P Gulseth Anticoagulation Consulting, Inc., Sioux Falls, SD  

Thaddaus Hellwig, PharmDBCPS, FASHP, Professor, Department of Pharmacy Practice, South Dakota State University College of Pharmacy and Allied Health Professions, Clinical Pharmacist, Sanford USD Medical Center, Coordinator of the SD Drug Education and Evaluation Program, Sioux Falls, SD 

Scott Kaatz, DO, MSc, FACP, SFHM, Clinical Professor of Medicine - Wayne State University, Senior Staff Hospitalist, Medical Director for Professional Development and Research, Division of Hospital Medicine, Henry Ford Hospital, Detroit, MI

Anne Rose, PharmD, Pharmacy Manager, UW Health, University of Wisconsin Hospital and Clinics, Madison, WI

Kelly M. Rudd, PharmD, FCCP, BCPS, CACP,  Director, Network Pharmacy Operations Bassett Healthcare Network, Cooperstown, NY

Planning Committee

2020 Planning Committee

David S. Adler, PharmD, University of California, San Francisco and San Diego, CA
Kate P. Cabral, PharmD, Albany College of Pharmacy and Health Sciences, Albany, NY
Nathan P. Clark, PharmD, FCCP, BCPS, Kaiser Permanente Colorado, Aurora, CO
William E. Dager, PharmD, UC Davis Medical Center, Sacramento, CA
John Fanikos, RPh, MBA, Brigham and Women’s Hospital, Boston, MA
Michael P. Gulseth, PharmD, Sanford USD Medical Center, Sioux Falls, SD
Cynthia Jackevicius, PharmD, MSc, BCPS, FCSHP, FAHA, Western University of Health Sciences, Pomona, CA, Program Chair
Kenneth A. Kellick, PharmD, VA Western NY Healthcare System, Buffalo, NY
Andrea L. Porter, PharmD, University of Wisconsin, Madison, WI, Conference Chair
Anne Rose, PharmD, University of Wisconsin Hospitals and Clinics, Madison, WI
Maureen A. Smythe, PharmD, FCCP, William Beaumont Hospital, Royal Oak, MI
Sarah A. Spinler, PharmD, Binghamton University School of Pharmacy and Pharmaceutical Studies, Binghamton, NY
Lynda Thomson, PharmD, Thomas Jefferson University, Philadelphia, PA

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin School of Pharmacy that the faculty, authors, planners, and other persons who may influence content of this activity disclose all relevant financial relationships with commercial interests in order to allow staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made available to attendees.

CE Credit

ICEP LogoAccreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

Accreditation Council for Pharmacy Education (ACPE)

A total of 7.0 hours of knowledge-based CE credit can be earned by successfully completing this activity.  CE credit information, based on verification of attendance and completion of the program assessment and evaluation, will be provided to NABP within 60 days after the activity completion.

Live CEU's: ACPE# JA0000358-0000-20-126-L01-P (3.5 hours/0.35 CEU's)
Enduring CEU's: ACPE# JA0000358-0000-20-113-H01-P (3.5 hours/0.35 CEU's)

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.7 CEUs or 7 hours.

Program Coordinator

Eric Buxton, PhD

Division of Pharmacy Professional Development
777 Highland Avenue
Madison, WI 53705
(608) 262-2431 FAX
(608) 265-2259
eric.buxton@wisc.edu